论文部分内容阅读
目的:探讨细菌性阴道病(BV)的发病情况和治疗方法。方法:对234例下生殖道不适患者进行检查,采用阴道涂片革兰氏染色查找线索细胞,测定阴道液pH值、阴道液质量及胺试验。确诊BV患者98例,口服泰力特治疗,分析疗效。结果:98例细菌性阴道病患者经泰力特治疗后10d复查,治愈率87%,总有效率935%。结论:对有生殖道炎症的妇女均应除外细菌性阴道病,泰力特是治疗细菌性阴道病的有效药物
Objective: To investigate the incidence and treatment of bacterial vaginosis (BV). Methods: A total of 234 cases of lower genital tract discomfort were examined. Vaginal smear Gram stain was used to find out the clue cells. The vaginal fluid pH value, vaginal fluid quality and amine test were determined. 98 cases of diagnosed BV patients, oral treatment of Telit, analysis of efficacy. Results: Ninety-eight patients with bacterial vaginosis were treated 10 days after treatment with telbivudine. The cure rate was 87% and the total effective rate was 935%. CONCLUSIONS: Women with reproductive tract inflammation should be excluded from bacterial vaginosis. Telit is an effective drug for the treatment of bacterial vaginosis